Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Int J Biol Macromol ; 272(Pt 1): 132845, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38830495

ABSTRACT

Brown seaweed-derived polysaccharides, notably fucoidan and laminarin, are known for their extensive array of bioactivities and physicochemical properties. However, the effects of upper digestive tract modification on the bioactive performance of fucoidan and laminarin fractions (FLFs) sourced from Australian native species are largely unknown. Here, the digestibility and bioaccessibility of FLFs were evaluated by tracking the dynamic changes in reducing sugar content (CR), profiling the free monosaccharide composition using LC-MS, and comparing high-performance gel permeation chromatography profile variation via LC-SEC-RI. The effects of digestive progression on bioactive performance were assessed by comparing the antioxidant and antidiabetic potential of FLFs and FLF digesta. We observed that molecular weight (Mw) decreased during gastric digestion indicating that FLF aggregates were disrupted in the stomach. During intestinal digestion, Mw gradually decreased and CR increased indicating cleavage of glycosidic bonds releasing free sugars. Although the antioxidant and antidiabetic capacities were not eliminated by the digestion progression, the bioactive performance of FLFs under a digestive environment was reduced contrasting with the same concentration level of the undigested FLFs. These data provide comprehensive information on the digestibility and bioaccessibility of FLFs, and shed light on the effects of digestive progression on bioactive expression.


Subject(s)
Antioxidants , Polysaccharides , Seaweed , Polysaccharides/chemistry , Polysaccharides/pharmacology , Seaweed/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Antioxidants/metabolism , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/drug effects , Molecular Weight , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/chemistry , Digestion/drug effects , Sulfates/chemistry , Glucans/chemistry , Glucans/pharmacology , Phaeophyceae/chemistry , Humans
2.
Dig Dis Sci ; 68(6): 2406-2413, 2023 06.
Article in English | MEDLINE | ID: mdl-36973521

ABSTRACT

BACKGROUND: Food-specific immunoglobulin G4 (FS-IgG4) is associated with eosinophilic esophagitis (EoE); however, it is not clear whether production is limited to the esophagus. AIMS: To assess FS-IgG4 levels in the upper gastrointestinal tract and plasma and compare these with endoscopic disease severity, tissue eosinophil counts, and patient-reported symptoms. METHODS: We examined prospectively banked plasma, throat swabs, and upper gastrointestinal biopsies (esophagus, gastric antrum, and duodenum) from control (n = 15), active EoE (n = 24), and inactive EoE (n = 8) subjects undergoing upper endoscopy. Patient-reported symptoms were assessed using the EoE symptom activity index (EEsAI). Endoscopic findings were evaluated using the EoE endoscopic reference score (EREFS). Peak eosinophils per high-power field (eos/hpf) were assessed from esophageal biopsies. Biopsy homogenates and throat swabs were normalized for protein content and assessed for FS-IgG4 to milk, wheat, and egg. RESULTS: Median FS-IgG4 for milk and wheat was significantly increased in the plasma, throat swabs, esophagus, stomach, and duodenum of active EoE subjects compared to controls. No significant differences for milk- or wheat-IgG4 were observed between active and inactive EoE subjects. Among the gastrointestinal sites sampled, FS-IgG4 levels were highest in the esophagus. Esophageal FS-IgG4 for all foods correlated significantly across all sites sampled (r ≥ 0.59, p < 0.05). Among subjects with EoE, esophageal FS-IgG4 correlated significantly with peak eos/hpf (milk and wheat) and total EREFS (milk). EEsAI scores and esophageal FS-IgG4 levels did not correlate. CONCLUSIONS: Milk and wheat FS-IgG4 levels are elevated in plasma and throughout the upper gastrointestinal tract in EoE subjects and correlate with endoscopic findings and esophageal eosinophilia.


Subject(s)
Eosinophilic Esophagitis , Food Hypersensitivity , Immunoglobulin G , Upper Gastrointestinal Tract , Humans , Immunoglobulin G/blood , Prospective Studies , Case-Control Studies , Eosinophils , Endoscopy, Gastrointestinal , Biomarkers , Upper Gastrointestinal Tract/metabolism , Male , Female , Adult , Middle Aged , Aged
3.
J Gastrointest Cancer ; 54(1): 290-293, 2023 Mar.
Article in English | MEDLINE | ID: mdl-35060100

ABSTRACT

Kaposi sarcoma (KS) is a low-grade vascular tumor caused by human herpes virus type 8 (HHV8). Gastrointestinal involvement of KS is rare and most commonly clinically silent. Gastrointestinal KS may mimic gastrointestinal stromal tumors (GISTs) histologically as the tumor formed by morphologically spindle-shaped cells, which is mostly located in the mucosa and submucosa. In the present study, we describe a case of Kaposi sarcoma that was first diagnosed in the gastrointestinal tract of a 73-year-old female patient who presented to the clinic with nausea and diarrhea. Immunohistochemical staining showed cytoplasmic CD117 expression both in stomach and colon biopsies. Although involvement of KS is rarely seen in the gastrointestinal tract (GIT), the differential diagnosis of low-grade spindle cell lesions without significant pleomorphism, KS should definitely be considered, and it should be known that CD117 positivity is also present in these neoplasms.


Subject(s)
Herpesvirus 8, Human , Sarcoma, Kaposi , Upper Gastrointestinal Tract , Female , Humans , Aged , Sarcoma, Kaposi/diagnosis , Sarcoma, Kaposi/etiology , Sarcoma, Kaposi/pathology , Pathologists , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/pathology , Stomach/pathology , Colon/pathology
4.
Arch Toxicol ; 96(6): 1905-1914, 2022 06.
Article in English | MEDLINE | ID: mdl-35504979

ABSTRACT

Subsequent to the dietary uptake of nitrate/nitrite in combination with acetaldehyde/ethanol, combination effects resulting from the sustained endogenous exposure to nitrite and acetaldehyde may be expected. This may imply locoregional effects in the upper gastrointestinal tract as well as systemic effects, such as a potential influence on endogenous formation of N-nitroso compounds (NOC). Salivary concentrations of the individual components nitrate and nitrite and acetaldehyde are known to rise after ingestion, absorption and systemic distribution, thereby reflecting their respective plasma kinetics and parallel secretion through the salivary glands as well as the microbial/enzymatic metabolism in the oral cavity. Salivary excretion may also occur with certain drug molecules and food constituents and their metabolites. Therefore, putative combination effects in the oral cavity and the upper digestive tract may occur, but this has remained largely unexplored up to now. In this Guest Editorial, published evidence on exposure levels and biokinetics of nitrate/nitrite/NOx, NOC and acetaldehyde in the organism is reviewed and knowledge gaps concerning combination effects are identified. Research is suggested to be initiated to study the related unresolved issues.


Subject(s)
Nitrites , Upper Gastrointestinal Tract , Acetaldehyde/metabolism , Humans , Nitrates/metabolism , Nitrites/metabolism , Nitroso Compounds/metabolism , Saliva/metabolism , Upper Gastrointestinal Tract/metabolism
5.
Carbohydr Polym ; 264: 118040, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-33910723

ABSTRACT

Citrus pectin can serve as a naturally digestion-resistant emulsifier, although how it achieves this effect is still unknown. In this study, the upper digestion fate of an emulsion stabilized by different concentrations of citrus pectin, and changes in its interfacial properties during digestion, were investigated. Emulsions stabilized by high-concentration citrus pectin (3 %) were relatively stable during digestion and had a lower free fatty acid (FFA) release rate than emulsions stabilized by low-concentration citrus pectin (1 %). At the low concentration, the citrus pectin interface had a thin absorbing layer and was largely replaced by bile salts, while at high concentration the citrus pectin interface possessed a uniform and thick adsorbing layer that resisted the replacement of bile salts and enabled lipase adsorption. This study has improved our understanding of the digestion of emulsion from the interface and will be useful for designing emulsion-based functional foods that can achieve targeted release.


Subject(s)
Citrus/chemistry , Digestion , Emulsifying Agents/chemistry , Pectins/chemistry , Upper Gastrointestinal Tract/metabolism , Adsorption , Bile Acids and Salts/metabolism , Emulsifying Agents/metabolism , Emulsions/chemistry , Fatty Acids, Nonesterified/metabolism , Humans , Lipase/metabolism , Lipolysis , Microscopy, Confocal/methods , Microscopy, Electron, Transmission/methods , Pectins/metabolism , Starch/metabolism , Whey Proteins/metabolism
6.
Lab Invest ; 101(7): 851-864, 2021 07.
Article in English | MEDLINE | ID: mdl-33859334

ABSTRACT

Endothelial and epithelial cells form physical barriers that modulate the exchange of fluid and molecules. The integrity of these barriers can be influenced by signaling through G protein-coupled receptors (GPCRs) and ion channels. Serotonin (5-HT) is an important vasoactive mediator of tissue edema and inflammation. However, the mechanisms that drive 5-HT-induced plasma extravasation are poorly defined. The Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel is an established enhancer of signaling by GPCRs that promote inflammation and endothelial barrier disruption. Here, we investigated the role of TRPV4 in 5-HT-induced plasma extravasation using pharmacological and genetic approaches. Activation of either TRPV4 or 5-HT receptors promoted significant plasma extravasation in the airway and upper gastrointestinal tract of mice. 5-HT-mediated extravasation was significantly reduced by pharmacological inhibition of the 5-HT2A receptor subtype, or with antagonism or deletion of TRPV4, consistent with functional interaction between 5-HT receptors and TRPV4. Inhibition of receptors for the neuropeptides substance P (SP) or calcitonin gene-related peptide (CGRP) diminished 5-HT-induced plasma extravasation. Supporting studies assessing treatment of HUVEC with 5-HT, CGRP, or SP was associated with ERK phosphorylation. Exposure to the TRPV4 activator GSK1016790A, but not 5-HT, increased intracellular Ca2+ in these cells. However, 5-HT pre-treatment enhanced GSK1016790A-mediated Ca2+ signaling, consistent with sensitization of TRPV4. The functional interaction was further characterized in HEK293 cells expressing 5-HT2A to reveal that TRPV4 enhances the duration of 5-HT-evoked Ca2+ signaling through a PLA2 and PKC-dependent mechanism. In summary, this study demonstrates that TRPV4 contributes to 5-HT2A-induced plasma extravasation in the airways and upper GI tract, with evidence supporting a mechanism of action involving SP and CGRP release.


Subject(s)
Capillary Permeability/drug effects , Lung/drug effects , Serotonin , TRPV Cation Channels , Upper Gastrointestinal Tract/drug effects , Animals , HEK293 Cells , Human Umbilical Vein Endothelial Cells , Humans , Lung/cytology , Lung/metabolism , Male , Mice , Mice, Inbred C57BL , Serotonin/genetics , Serotonin/metabolism , Serotonin/pharmacology , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism , Upper Gastrointestinal Tract/cytology , Upper Gastrointestinal Tract/metabolism
7.
Cell Rep ; 34(10): 108819, 2021 03 09.
Article in English | MEDLINE | ID: mdl-33691112

ABSTRACT

The upper gastrointestinal tract, consisting of the esophagus, stomach, and duodenum, controls food transport, digestion, nutrient uptake, and hormone production. By single-cell analysis of healthy epithelia of these human organs, we molecularly define their distinct cell types. We identify a quiescent COL17A1high KRT15high stem/progenitor cell population in the most basal cell layer of the esophagus and detect substantial gene expression differences between identical cell types of the human and mouse stomach. Selective expression of BEST4, CFTR, guanylin, and uroguanylin identifies a rare duodenal cell type, referred to as BCHE cell, which likely mediates high-volume fluid secretion because of continual activation of the CFTR channel by guanylin/uroguanylin-mediated autocrine signaling. Serotonin-producing enterochromaffin cells in the antral stomach significantly differ in gene expression from duodenal enterochromaffin cells. We, furthermore, discover that the histamine-producing enterochromaffin-like cells in the oxyntic stomach express the luteinizing hormone, yet another member of the enteroendocrine hormone family.


Subject(s)
Duodenum/cytology , Esophagus/cytology , Stomach/cytology , Upper Gastrointestinal Tract/cytology , Animals , Autoantigens/genetics , Autoantigens/metabolism , Bestrophins/genetics , Bestrophins/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Duodenum/metabolism , Duodenum/pathology , Esophagus/metabolism , Esophagus/pathology , Gene Expression , Humans , Intestinal Mucosa/cytology , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Keratin-15/genetics , Keratin-15/metabolism , Luteinizing Hormone/genetics , Luteinizing Hormone/metabolism , Mice , Mice, Inbred C57BL , Non-Fibrillar Collagens/genetics , Non-Fibrillar Collagens/metabolism , Single-Cell Analysis , Stem Cells/cytology , Stem Cells/metabolism , Stomach/metabolism , Stomach/pathology , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/pathology , Collagen Type XVII
8.
Histopathology ; 78(1): 187-214, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33382495

ABSTRACT

Approximately one-third of extranodal non-Hodgkin lymphomas involve the gastrointestinal (GI) tract, with the vast majority being diagnosed in the stomach, duodenum, or proximal small intestine. A few entities, especially diffuse large B-cell lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, represent the majority of cases. In addition, there are diseases specific to or characteristic of the GI tract, and any type of systemic lymphoma can present in or disseminate to these organs. The recent advances in the genetic and molecular characterisation of lymphoid neoplasms have translated into notable changes in the classification of primary GI T-cell neoplasms and the recommended diagnostic approach to aggressive B-cell tumours. In many instances, diagnoses rely on morphology and immunophenotype, but there is an increasing need to incorporate molecular genetic markers. Moreover, it is also important to take into consideration the endoscopic and clinical presentations. This review gives an update on the most recent developments in the pathology and molecular pathology of upper GI lymphoproliferative diseases.


Subject(s)
Gastrointestinal Neoplasms/diagnosis , Lymphoma/diagnosis , Upper Gastrointestinal Tract/pathology , Diagnosis, Differential , Gastrointestinal Neoplasms/metabolism , Gastrointestinal Neoplasms/pathology , Humans , Immunophenotyping , Lymphoma/metabolism , Lymphoma/pathology , Upper Gastrointestinal Tract/metabolism
9.
Sci Rep ; 10(1): 6796, 2020 04 22.
Article in English | MEDLINE | ID: mdl-32321942

ABSTRACT

After the accident at the TEPCO Fukushima Daiichi Nuclear Power Plant in 2011, it became important to study radiation dynamics, assess internal radiation exposure and specify factors affecting radionuclide variation in wildlife. Therefore, it is necessary to investigate which physicochemical fractions of radiocaesium (137Cs) are absorbed from ingested material in species with high activity concentrations of 137Cs, such as wild boar. This study analysed the physicochemical fractions of 137Cs in the stomach contents of wild boar to evaluate the transfer from ingested food to muscle. The 137Cs activity concentration in muscle showed a significantly positive relationship with the 137Cs activity concentration in the exchangeable fraction, and the sum of the 137Cs activity concentrations in the exchangeable and bound to organic matter fractions. Seasonal variations were also found in the 137Cs activity concentration in the exchangeable fraction, and the sum of the 137Cs activity concentrations in the exchangeable and bound to organic matter fractions. These findings suggest that the proportions of the physicochemical fractions of 137Cs in the exchangeable and bound to organic matter fractions in the stomach contents are important factors affecting the increases and seasonal dynamics of the activity concentrations of 137Cs in wild boar muscle.


Subject(s)
Cesium Radioisotopes/metabolism , Muscles/metabolism , Radiation Monitoring/methods , Stomach , Sus scrofa/metabolism , Upper Gastrointestinal Tract/metabolism , Animals , Fukushima Nuclear Accident , Geography , Japan , Seasons , Viscera/metabolism
10.
Cancer Lett ; 475: 14-21, 2020 04 10.
Article in English | MEDLINE | ID: mdl-32004573

ABSTRACT

The upper gastrointestinal (GI) tumors are multifactorial diseases associated with a combination of oncogenes and environmental factors. Currently, surgery, chemotherapy, radiotherapy and immunotherapy are relatively effective treatment options for the patients with these tumors. However, the asymptomatic phenotype of these tumors during the early stages poses as a significant limiting factor to diagnosis and often renders treatments ineffective. Therefore, new early diagnosis and effective therapy for upper GI tumors are urgently needed. Ca2+ is a pivotal intracellular second messenger and plays a crucial role in living cells by regulating several processes from cell division to death. The aberrant Ca2+ homeostasis is related to many human pathological conditions and diseases, including cancer, and thus the changes in the expression and function of plasma membrane Ca2+ permeable channels and sodium/calcium exchangers are frequently described in tumorigenesis and tumor development of the upper GI tract, including voltage-gated Ca2+ channels (VGCC), transient receptor potential (TRP) channels, store-operated channels (SOC) and Na+/Ca2+ exchanger (NCX). This review will summarize the current knowledge about plasma membrane Ca2+ permeable channels and sodium/calcium exchangers in the upper GI tumors and provide a synopsis of recent advancements on the role and involvement of these channels in upper GI tumors as well as a discussion of the possible strategies to target these channels and exchangers for diagnosis and therapy of the upper GI tumors.


Subject(s)
Calcium/metabolism , Cell Membrane/metabolism , Gastrointestinal Neoplasms/pathology , Ion Channels/metabolism , Sodium-Calcium Exchanger/metabolism , Sodium/metabolism , Upper Gastrointestinal Tract/pathology , Animals , Carcinogenesis/metabolism , Carcinogenesis/pathology , Gastrointestinal Neoplasms/metabolism , Humans , Upper Gastrointestinal Tract/metabolism
11.
Pharm Res ; 37(3): 42, 2020 Jan 27.
Article in English | MEDLINE | ID: mdl-31989335

ABSTRACT

PURPOSE: The design of biorelevant conditions for in vitro evaluation of orally administered drug products is contingent on obtaining accurate values for physiologically relevant parameters such as pH, buffer capacity and bile salt concentrations in upper gastrointestinal fluids. METHODS: The impact of sample handling on the measurement of pH and buffer capacity of aspirates from the upper gastrointestinal tract was evaluated, with a focus on centrifugation and freeze-thaw cycling as factors that can influence results. Since bicarbonate is a key buffer system in the fasted state and is used to represent conditions in the upper intestine in vitro, variations on sample handling were also investigated for bicarbonate-based buffers prepared in the laboratory. RESULTS: Centrifugation and freezing significantly increase pH and decrease buffer capacity in samples obtained by aspiration from the upper gastrointestinal tract in the fasted state and in bicarbonate buffers prepared in vitro. Comparison of data suggested that the buffer system in the small intestine does not derive exclusively from bicarbonates. CONCLUSIONS: Measurement of both pH and buffer capacity immediately after aspiration are strongly recommended as "best practice" and should be adopted as the standard procedure for measuring pH and buffer capacity in aspirates from the gastrointestinal tract. Only data obtained in this way provide a valid basis for setting the physiological parameters in physiologically based pharmacokinetic models.


Subject(s)
Bicarbonates/chemistry , Bile Acids and Salts/chemistry , Body Fluids/chemistry , Body Fluids/metabolism , Upper Gastrointestinal Tract/chemistry , Upper Gastrointestinal Tract/metabolism , Buffers , Famotidine/administration & dosage , Famotidine/metabolism , Gastrointestinal Absorption , Humans , Hydrogen-Ion Concentration , Ibuprofen/administration & dosage , Ibuprofen/metabolism , Intestine, Small , Salts/chemistry , Stomach
12.
Int J Food Sci Nutr ; 71(5): 540-548, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31791183

ABSTRACT

Fusarium mycotoxins are common contaminants in cereals and often co-occur with plant-derived mycotoxin sugar conjugates. Several of these modified mycotoxins are not degraded in the small intestine and hence carried through to the large intestine where microbial transformation may occur. This study aims to assess the gastrointestinal stability of the trichothecenes HT-2 toxin (HT-2), HT-2-ß-glucoside (HT-2-Glc), diacetoxyscirpenol (DAS), DAS-α-glucoside (DAS-Glc) and fumonisin B1 (FB1), N-(1-deoxy-d-fructos-1-yl) fumonisin-B1 (NDF-FB1). All tested modified mycotoxins were stable under upper gastrointestinal (GI) conditions. In faecal batch culture experiments, HT-2-Glc was hydrolysed efficiently and no further microbial biotransformation of HT-2 was observed. DAS-Glc hydrolysis was slow and DAS was de-acetylated to 15-monoacetoxyscripenol. NDF-FB1 was hydrolysed at the slowest rate and FB1 accumulation varied between donor samples. Our results demonstrate that all tested modified mycotoxins are stable in the upper GI tract and efficiently hydrolysed by human gut microbiota, thus potentially contributing to colonic toxicity. Hence the microbial biotransformation of any novel modified mycotoxins needs to be carefully evaluated.


Subject(s)
Edible Grain/chemistry , Fumonisins/metabolism , Fusarium , Gastrointestinal Microbiome , Glucosides/metabolism , Intestine, Large , Trichothecenes/metabolism , Adult , Biotransformation , Female , Food Contamination , Gastrointestinal Transit , Humans , Hydrolysis , Intestine, Large/metabolism , Intestine, Large/microbiology , Intestine, Small/metabolism , Male , Masked Mycotoxins/metabolism , Middle Aged , Mycotoxins/metabolism , Poaceae , T-2 Toxin/analogs & derivatives , T-2 Toxin/metabolism , Upper Gastrointestinal Tract/metabolism
13.
Diabetes ; 68(6): 1143-1155, 2019 06.
Article in English | MEDLINE | ID: mdl-30936143

ABSTRACT

This study assessed the effectiveness of surgical sympathetic denervation of the common hepatic artery (CHADN) in improving glucose tolerance. CHADN eliminated norepinephrine content in the liver and partially decreased it in the pancreas and the upper gut. We assessed oral glucose tolerance at baseline and after 4 weeks of high-fat high-fructose (HFHF) feeding. Dogs were then randomized to sham surgery (SHAM) (n = 9) or CHADN surgery (n = 11) and retested 2.5 or 3.5 weeks later while still on the HFHF diet. CHADN improved glucose tolerance by ∼60% in part because of enhanced insulin secretion, as indicated by an increase in the insulinogenic index. In a subset of dogs (SHAM, n = 5; CHADN, n = 6), a hyperinsulinemic-hyperglycemic clamp was used to assess whether CHADN could improve hepatic glucose metabolism independent of a change in insulin release. CHADN reduced the diet-induced defect in net hepatic glucose balance by 37%. In another subset of dogs (SHAM, n = 4; CHADN, n = 5) the HFHF diet was continued for 3 months postsurgery and the improvement in glucose tolerance caused by CHADN continued. In conclusion, CHADN has the potential to enhance postprandial glucose clearance in states of diet-induced glucose intolerance.


Subject(s)
Diet, High-Fat , Dietary Sugars , Glucose Intolerance/metabolism , Hepatic Artery/innervation , Liver/metabolism , Norepinephrine/metabolism , Sympathectomy , Animals , Dogs , Fructose , Glucose Clamp Technique , Glucose Tolerance Test , Male , Pancreas/metabolism , Random Allocation , Upper Gastrointestinal Tract/metabolism
14.
PLoS One ; 14(4): e0214859, 2019.
Article in English | MEDLINE | ID: mdl-31002668

ABSTRACT

In developing an oral bait BCG vaccine against tuberculosis in badgers we wanted to understand the conditions of the gastrointestinal tract and their impact on vaccine viability. Conditions mimicking stomach and small-intestine caused substantial reduction in BCG viability. We performed in vivo experiments using a telemetric pH monitoring system and used the data to parameterise a dynamic in vitro system (TIM-1) of the stomach and small intestine. Some BCG died in the stomach compartment and through the duodenum and jejunum compartments. BCG survival in the stomach was greatest when bait was absent but by the time BCG reached the jejunum, BCG viability was not significantly affected by the presence of bait. Our data suggest that from a starting quantity of 2.85 ± 0.45 x 108 colony-forming units of BCG around 2 log10 may be killed before delivery to the intestinal lymphoid tissue. There are economic arguments for reducing the dose of BCG to vaccinate badgers orally. Our findings imply this could be achieved if we can protect BCG from the harsh environment of the stomach and duodenum. TIM-1 is a valuable, non-animal model with which to evaluate and optimise formulations to maximise BCG survival in the gastrointestinal tract.


Subject(s)
BCG Vaccine/administration & dosage , BCG Vaccine/immunology , Mustelidae/immunology , Mustelidae/microbiology , Mycobacterium bovis/immunology , Vaccination/veterinary , Administration, Oral , Animals , Bacterial Load , Disease Reservoirs/microbiology , Hydrogen-Ion Concentration , In Vitro Techniques , Microbial Viability/immunology , Models, Biological , Tuberculosis/immunology , Tuberculosis/prevention & control , Tuberculosis/veterinary , Upper Gastrointestinal Tract/immunology , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/microbiology , Vaccination/methods
15.
Benef Microbes ; 10(1): 77-87, 2019 Feb 08.
Article in English | MEDLINE | ID: mdl-30694101

ABSTRACT

The aim of this study was to assess the germination, survival and metabolic activity of the probiotic Bacillus coagulans GBI-30, 6086 [GanedenBC30] (BC30) in a dynamic, computer controlled in vitro model of the gastrointestinal (GI) tract, simulating human adults. Experiments were performed in the presence of a meal to maximise germination, due to the presence of germination-triggers. Both an upper GI tract (stomach and small intestine; TIM-1) and a colon model (TIM-2) were used, where material exiting TIM-1 was added to TIM-2. Spores of BC30 were introduced in the gastric compartment of TIM-1 and samples were taken immediately after the pylorus. Moreover, for 6 h, every hour the ileal efflux was collected and a subsample was plated for viable counts (spores and germinated cells). The remainder of the sample was fed to TIM-2, and after 24 h another sample was taken and tested for viable counts. In addition, samples were taken from the dialysates of the model and analysed using LC-MS/MS to determine bacterial metabolites and digestion products. Survival after transit through the gastric compartment was high (97%) and most cells were still in the spore form (76%). Survival after transit through TIM-1 was on average 51%, meaning that on average half of the orally provided spores was found back as cfu on the agar plates. Of these on average 93% were germinated cells and only 7% were spores. 24 h after the start of the experiments germination had increased in TIM-2 to 97% vegetative cells, and only 3% spores. No further loss of viability was observed in TIM-2. In terms of metabolic activity, increased levels of amino acids, dipeptides and citric acid cycle metabolites were found compared to experiments in the absence of BC30. In conclusion, BC30 spores germinate to a large extent (>90%) in the presence of germination triggers in the small intestine in a model that closely mimics the physiological conditions of human adults. Of the oral dose, as much as half of the cells survived transit through the upper GI tract, and based on the metabolite profile, these cells were metabolically active. Either these cells or the enzymes released from the dead cells aided in digestion of the meal. These insights help explain some of the observations in previous experiments, and support the understanding of the mechanism of action of the probiotic BC30.


Subject(s)
Bacillus coagulans/physiology , Computer Simulation , Gastrointestinal Tract/microbiology , Models, Biological , Probiotics , Bacillus coagulans/enzymology , Bacillus coagulans/growth & development , Colon/microbiology , Gastrointestinal Tract/metabolism , Humans , In Vitro Techniques , Meals , Microbial Viability , Spores, Bacterial/growth & development , Spores, Bacterial/metabolism , Spores, Bacterial/physiology , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/microbiology
16.
J Agric Food Chem ; 66(47): 12580-12593, 2018 Nov 28.
Article in English | MEDLINE | ID: mdl-30406656

ABSTRACT

Although in vitro studies to identify interactions between food components and the colonic microbiota employ distinct methods to mimic upper gastrointestinal (GI) tract digestion, the effects of differences in protocols on fermentation have not been rigorously addressed. Here, we compared two widely used upper GI tract digestion methods on four different cereal brans in fermentations by fecal microbiota to test the hypotheses that (1) different methods are varyingly efficient in removing accessible starches and proteins from dietary components and (2) these result in cereal-specific differences in fermentation by fecal microbiota. Our results supported both hypotheses, in that the methods differed significantly in bran starch and protein retention and that the effects were cereal-specific. Furthermore, these differences impacted fermentation by the fecal microbiota of healthy donors, altering both short-chain fatty acid production and microbial community composition. These data suggest that digestion methods should be standardized across laboratories for in vitro fiber fermentation studies.


Subject(s)
Dietary Fiber/metabolism , Edible Grain/metabolism , Feces/microbiology , Gastrointestinal Microbiome , Upper Gastrointestinal Tract/microbiology , Adult , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/metabolism , Digestion , Edible Grain/classification , Fatty Acids, Volatile/metabolism , Female , Fermentation , Humans , Male , Models, Biological , Upper Gastrointestinal Tract/metabolism
17.
Food Funct ; 9(11): 5868-5879, 2018 Nov 14.
Article in English | MEDLINE | ID: mdl-30362482

ABSTRACT

Akkermansia muciniphila, an abundant member of the human gut microbiota, has been suggested as a potential next-generation probiotic. However, its high sensitivity to oxygen limits the development of dosage protocols. Here, we describe microencapsulation, in a xanthan and gellan gum matrix, and a subsequent freeze-drying protocol for A. muciniphila DSM22959. For comparison Lactobacillus plantarum subsp. plantarum ATCC14917 was microencapsulated and freeze-dried using similar protocols. Four different mixtures were tested for cryoprotective properties: sucrose 5% plus trehalose 5%; agave syrup 10%; skim milk 10%, glucose 1%, yeast extract 0.5%, and mannitol 2.5%; as well as peptone 0.1% plus sorbitol 1.2%. Milli-Q-water served as control. Only cryoprotectant solutions with high sugar or protein content significantly improved the survival of both strains during freeze-drying. Microencapsulated cells were stored aerobically or anaerobically for 1 month at 4 °C or 25 °C. Survival of A. muciniphila was significantly better when stored anaerobically at 4 °C. The survival of microencapsulated L. plantarum, was relatively stable at both temperatures under anaerobic conditions. Survival of microencapsulated cells was compared with that of free cells during in vitro simulated upper gastrointestinal tract (GIT) transit at fasted and fed state. During in vitro simulated stomach passage, encapsulation significantly improved survival and viable cells remained at relevant levels after the entire simulated upper GIT transit. In conclusion, we here report a protocol for encapsulating A. muciniphila giving acceptable storage stability and enhancing survival during in vitro simulated upper GIT transit and thus constitutes an important step towards enabling future use of this important member of the human colonic microbiota as a probiotic.


Subject(s)
Freeze Drying , Lactobacillus plantarum/growth & development , Microbial Viability , Probiotics , Verrucomicrobia/growth & development , Polysaccharides, Bacterial/chemistry , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/microbiology
18.
Rom J Morphol Embryol ; 58(1): 139-144, 2017.
Article in English | MEDLINE | ID: mdl-28523309

ABSTRACT

The differential diagnosis between reactive atypia and non-invasive neoplasia (or dysplasia) can be challenging in the case of small conventional forceps biopsy specimens of the stomach. Despite the existence of several classifications for neoplastic epithelial lesions of the stomach, there are few auxiliary tools for aiding in this decision besides standard stains. We studied the utility of Ki-67 and p53 immunohistochemistry in this setting and their clinico-pathological correlations, based on a set of 99 cases with cytological or architectural atypia reviewed by three pathologists. We also tested a digitalized method based on the ImageJ software for the evaluation of Ki-67 expression to determine whether this could be of an additional help. CONCLUSIONS: Ki-67 and p53 expression correlates well with microscopic and morphological modifications in biopsies and can be a useful tool in confirming or dismissing an impression of dysplasia in routine pathological work-up. Digital processing is cumbersome and of limited value and it could only be of additional help if more automated methods are developed.


Subject(s)
Biopsy/methods , Ki-67 Antigen/biosynthesis , Stomach/pathology , Tumor Suppressor Protein p53/metabolism , Upper Gastrointestinal Tract/pathology , Adult , Aged , Aged, 80 and over , Female , Gastric Mucosa/metabolism , Gastritis/metabolism , Gastritis/pathology , Humans , Immunohistochemistry , Male , Metaplasia/metabolism , Metaplasia/pathology , Middle Aged , Retrospective Studies , Tumor Suppressor Protein p53/biosynthesis , Upper Gastrointestinal Tract/metabolism
19.
Drug Deliv Transl Res ; 6(3): 299-307, 2016 06.
Article in English | MEDLINE | ID: mdl-26902907

ABSTRACT

The purpose of this investigation was to prepare and characterize acyclovir loaded floating microspheres by emulsification solvent evaporation method. Piperine was added to investigate its effect on acyclovir bioavailability. The microspheres were characterized for size, shape, entrapment efficiency, in vitro drug release, and in vivo pharmacokinetic parameters. The morphological characterization of microspheres was done using a scanning electron microscope. The microspheres were spherical and had particle size in the range of 400 to 525 µm. The percent drug entrapment efficiency varied between 56.12 ± 1.32 % to 87.32 ± 5.28 %. The drug release was decreased at higher polymer concentrations. Nearly two times higher AUC0-24 value of acyclovir-loaded piperine containing microspheres (15614.13 ± 6953.13 ng h ml(-1)) was observed as compared to the drug solution (7552.33 ± 3219.09 ng h ml(-1)). Under the accelerated storage conditions, the best selected formulation was found to be stable for 90 days. The preliminary results of this study suggest that the developed microspheres containing acyclovir could enhance drug entrapment efficiency, reduce initial burst release, and prolong the drug release with enhanced bioavailability.


Subject(s)
Acyclovir/pharmacokinetics , Alkaloids/pharmacokinetics , Benzodioxoles/pharmacokinetics , Drug Delivery Systems/methods , Microspheres , Piperidines/pharmacokinetics , Polyunsaturated Alkamides/pharmacokinetics , Upper Gastrointestinal Tract/metabolism , Acyclovir/blood , Acyclovir/chemistry , Alkaloids/pharmacology , Animals , Benzodioxoles/pharmacology , Biological Availability , Drug Liberation , Drug Stability , Microscopy, Electron, Scanning , Particle Size , Piperidines/pharmacology , Polyunsaturated Alkamides/pharmacology , Rats , Solubility
20.
Food Microbiol ; 53(Pt A): 18-29, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26611166

ABSTRACT

Streptococcus thermophilus, a lactic acid bacterium used to produce yogurts and cheeses is more and more considered for its potential probiotic properties. This implies that additional information should be obtained regarding its survival and metabolic activity in the human Gastro-Intestinal Tract (GIT). In this study, we screened 30 S. thermophilus strains for urease, small heat shock protein, and amino-acid decarboxylase functions which may play a role in survival in the upper part of the GIT. The survival kinetics of 4 strains was investigated using the TIM, a physiologically relevant in vitro dynamic gastric and small intestinal model. The three strains LMD9, PB18O and EBLST20 showed significantly higher survival than CNRZ21 in all digestive compartments of the TIM, which may be related to the presence of urease and heat shock protein functions. When LMD9 bacterial cells were delivered in a fermented milk formula, a significant improvement of survival in the TIM was observed compared to non-fermented milk. With the RIVET (Recombinase In Vivo Expression Technology) method applied to the LMD9 strain, a promoter located upstream of hisS, responsible for the histidyl-transfer RNA synthesis, was found to be specifically activated in the artificial stomach. The data generated on S. thermophilus survival and its adaptation capacities to the digestive tract are essential to establish a list of biomarkers useful for the selection of probiotic strains.


Subject(s)
Microbial Viability , Streptococcus thermophilus/physiology , Upper Gastrointestinal Tract/metabolism , Upper Gastrointestinal Tract/microbiology , Yogurt/microbiology , Adaptation, Physiological , Animals , Digestion , Gastric Acid/metabolism , Genes, Bacterial , Humans , Milk/microbiology , Models, Anatomic , Probiotics/metabolism , Streptococcus thermophilus/genetics , Streptococcus thermophilus/metabolism , Urease/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...